Live Breaking News & Updates on Artis Senior

Stay updated with breaking news from Artis senior. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Abrocitinib Approved for Atopic Dermatitis in Europe

The oral JAK inhibitor was approved for treating AD earlier in 2021 for treating AD in the United Kingdom, Japan, and Korea, and is under review at the US Food and Drug Administration. ....

United Kingdom , European Commission , Drug Administration , Medicinal Products , Human Use , European Medicines Agency , Atopic Dermatitis , Us Food And Drug Administration , Nited States Food And Drug Administration , United Kingdom Site Content , Antiretroviral Therapy , Antiretroviral Therapy Art , Herapy Antiretroviral , Hiv Infection , Nucleoside Reverse Transcriptase Inhibitors , Ucleoside Analog , Nhibitor Nuc ,

Bosco Martis opens up about his directorial debut

Renowned choreographer Bosco Martis is all set to make his directorial debut with the film Rocket Gang . ....

Nikita Dutta , Bosco Martis , Rocket Gang , Aditya Seal , Ews India ,

Guselkumab Deemed Effective for PsA Previously Treated With TNFi

COSMOS trial results in patients with psoriatic arthritis fit with the expectation that "people who ve previously failed a TNF inhibitor might be a little less likely to respond to guselkumab." ....

United States , Northwestern University , United Kingdom , Ericm Ruderman , Laurac Coates , University Of Oxford , American College Of Rheumatology , Division Of Rheumatology At Northwestern University , Certain Patients , American College , Psoriatic Arthritis , Oint Inflammation , Biologic Therapy , Antiretroviral Therapy , Antiretroviral Therapy Art , Herapy Antiretroviral , Hiv Infection , Nucleoside Reverse Transcriptase Inhibitors , Ucleoside Analog , Nhibitor Nucleoside Reverse Transcriptase , Prostate Carcinoma , Alignant Prostate Neoplasm , Rostate C ,

Daily Oral PCSK9 Inhibitor Encouraging in Phase 1 Trials

What if the cholesterol-crushing efficacy of current PCSK9 inhibitors came in a pill instead of a syringe? That s one possibility for a Merck agent in the earliest stages of human trials. ....

New Jersey , United States , Washington University , Annec Goldberg , Douglasg Johns , Sanofi Regeneron , American Heart Association , European Union , Washington University School Of Medicine , Scientific Sessions , Washington University School , Ipid Management , Roprotein Convertase Subtilisin Kexin Type 9 , Nucleoside Reverse Transcriptase Inhibitors , Ucleoside Analog , Nhibitor Nucleoside Reverse Transcriptase , Translational Research , Ranslative Research , Translational Science , Clinical Research , Clinical Trials , Linical Studies , Low Ldl Cholesterol ,

When to Treat as Important as Which Drug to Use in WM

When to initiate treatment for patients newly diagnosed with Waldenstrom macroglobulinemia (WM) is as important as which drug to use, says expert. ....

United States , Dana Farber Cancer Institute , Jorge Castillo , Stephen Ansell , International Waldenstrom Macroglobulinemia Foundation , Virtual Educational Forum , Mayo Clinic , International Waldenstrom , Macroglobulinemia Foundation , Antineoplastic Drug , Nti Cancer Agents , Antiretroviral Therapy , Antiretroviral Therapy Art , Herapy Antiretroviral , Hiv Infection , Nucleoside Reverse Transcriptase Inhibitors , Ucleoside Analog , Nhibitor Nuc ,